Antigenics L.L.C. preclinical data

Antigenics announced that animal testing has demonstrated that its tumor-derived, heat-shock protein product increased survival and eliminated micrometastases in mice with primary and metastasized lung and melanoma cancers, as reported at the Cancer Research Institute Conference on Cancer Vaccines.

Heat shock proteins are transporter molecules that bring antigens to the MHC molecules that display them to stimulate an immune response. ...